This study is testing a new oral drug called ART6043 for people with advanced or metastatic solid tumors. It will check the safety and early signs of effectiveness of ART6043 when taken by itself and when combined with an existing cancer drug, olaparib. The trial will enroll abou…
Phase: PHASE1, PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC